Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Lifevantage Debt to Equity Ratio 2010-2024 | LFVN

Current and historical debt to equity ratio values for Lifevantage (LFVN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Lifevantage debt/equity for the three months ending December 31, 2024 was 0.00.
  
Lifevantage Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $0.04B $0.03B 1.29
2024-09-30 $0.03B $0.03B 1.22
2024-06-30 $0.03B $0.03B 1.32
2024-03-31 $0.04B $0.03B 1.29
2023-12-31 $0.04B $0.03B 1.30
2023-09-30 $0.04B $0.03B 1.27
2023-06-30 $0.03B $0.04B 0.91
2023-03-31 $0.03B $0.03B 1.01
2022-12-31 $0.04B $0.03B 1.13
2022-09-30 $0.04B $0.03B 1.12
2022-06-30 $0.04B $0.03B 1.24
2022-03-31 $0.04B $0.03B 1.12
2021-12-31 $0.04B $0.04B 1.08
2021-09-30 $0.04B $0.04B 1.03
2021-06-30 $0.04B $0.04B 1.14
2021-03-31 $0.04B $0.04B 1.11
2020-12-31 $0.04B $0.04B 1.10
2020-09-30 $0.04B $0.03B 1.06
2020-06-30 $0.03B $0.03B 0.77
2020-03-31 $0.02B $0.03B 0.83
2019-12-31 $0.03B $0.03B 0.89
2019-09-30 $0.03B $0.03B 0.89
2019-06-30 $0.03B $0.03B 1.03
2019-03-31 $0.03B $0.03B 1.19
2018-12-31 $0.03B $0.02B 1.57
2018-09-30 $0.03B $0.02B 1.21
2018-06-30 $0.03B $0.02B 1.33
2018-03-31 $0.03B $0.02B 1.64
2017-12-31 $0.03B $0.02B 1.77
2017-09-30 $0.03B $0.02B 1.84
2017-06-30 $0.03B $0.02B 2.12
2017-03-31 $0.03B $0.01B 2.36
2016-12-31 $0.03B $0.02B 2.21
2016-09-30 $0.04B $0.01B 2.54
2016-06-30 $0.04B $0.01B 3.78
2016-03-31 $0.04B $0.01B 3.99
2015-12-31 $0.04B $0.01B 5.41
2015-09-30 $0.04B $0.01B 7.65
2015-06-30 $0.04B $0.00B 10.96
2015-03-31 $0.04B $0.00B 15.58
2014-12-31 $0.05B $0.01B 10.23
2014-09-30 $0.05B $0.01B 6.88
2014-06-30 $0.05B $0.00B 12.53
2014-03-31 $0.07B $0.00B 24.78
2013-12-31 $0.06B $-0.00B -116.68
2013-09-30 $0.02B $0.04B 0.55
2013-06-30 $0.02B $0.03B 0.64
2013-03-31 $0.02B $0.04B 0.56
2012-12-31 $0.02B $0.04B 0.57
2012-09-30 $0.02B $0.03B 0.47
2012-06-30 $0.02B $0.03B 0.57
2012-03-31 $0.01B $0.02B 0.48
2011-12-31 $0.02B $0.01B 1.64
2011-09-30 $0.03B $-0.02B -2.06
2011-06-30 $0.03B $-0.02B -1.60
2011-03-31 $0.02B $-0.01B -1.73
2010-12-31 $0.01B $-0.01B -2.63
2010-09-30 $0.02B $-0.01B -1.61
2010-06-30 $0.02B $-0.02B -1.39
2010-03-31 $0.02B $-0.01B -1.50
2009-12-31 $0.01B $-0.01B -1.88
2009-09-30 $0.01B $-0.01B -1.86
2009-06-30 $0.01B $-0.01B -1.84
2009-03-31 $0.01B $-0.00B -2.35
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.211B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Pro-Dex (PDEX) United States $0.108B 16.47